21762-22-1 Usage
Derivative of butyric acid
2-(3-nitro-phenyl)-butyric acid is derived from butyric acid, which is a short-chain fatty acid with a 4-carbon backbone.
Presence of a nitro group and a phenyl ring
2-(3-nitro-phenyl)-butyric acid has a nitro group (-NO2) attached to a phenyl ring (a 6-carbon ring with delocalized electrons) which is attached to the 3rd carbon of the butyric acid backbone.
Potential pharmacological properties
2-(3-nitro-phenyl)-butyric acid has been studied for its potential anti-inflammatory and neuroprotective effects, which could make it a useful compound in the development of new drugs.
Used in the synthesis of pharmaceuticals and organic compounds
2-(3-nitro-phenyl)-butyric acid can be used as a building block in the synthesis of other compounds, including pharmaceuticals and organic compounds.
Applications in research and development
2-(3-nitro-phenyl)-butyric acid may have applications in the fields of research and development, particularly in the study of neurological disorders and inflammatory conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 21762-22-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,7,6 and 2 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 21762-22:
(7*2)+(6*1)+(5*7)+(4*6)+(3*2)+(2*2)+(1*2)=91
91 % 10 = 1
So 21762-22-1 is a valid CAS Registry Number.
21762-22-1Relevant academic research and scientific papers
Aniline derivatives possessing an inhibitory effect of nitric oxide synthase
-
, (2008/06/13)
Compounds represented by the general formula (1): ? (where R1is SR6or NR7R8, where R6is typically an alkyl group having 1-6 carbon atoms, R7is a hydrogen atom, an alkyl group having 1-6 carbon atoms or a nitro group, and R8is a hydrogen atom or an alkyl group having 1-6 carbon atoms; R2and R3are each typically a hydrogen atom or an alkyl group having 1-6 carbon atoms; R4is a hydrogen atom, an alkyl group having 1-6 carbon atoms or an amidino group of which the amine portion may be substituted by an alkyl or nitro group; R5is a hydrogen atom or an alkyl group having 1-6 carbon atoms; Y1, Y2, Y3and Y4which may be the same or different are each typically a hydrogen atom, a halogen atom or an alkoxy group having 1-6 carbon atoms; n and m are each an integer of 0 or 1), or possible stereoisomers or optically active forms of the compounds or pharmaceutically acceptable salts thereof. The compounds possess a potent nitric oxide synthase inhibiting activity and are useful as therapeutics of cerebrovascular diseases.
